Manawan, Francis-vegie P.

HRN: 26-76-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2025
CEFTRIAXONE 1G (VIAL)
03/01/2025
03/08/2025
IV
2g
OD
Open Fracture
Waiting Final Action 
03/07/2025
CO-AMOXICLAV 625MG (TAB)
03/07/2025
03/14/2025
PO
625mg
Q8
Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: